Pan-erbB inhibition potentiates BRAF inhibitors for melanoma treatment
about
Combinatorial drug screening and molecular profiling reveal diverse mechanisms of intrinsic and adaptive resistance to BRAF inhibition in V600E BRAF mutant melanomas.Small-molecule inhibitors of the receptor tyrosine kinases: promising tools for targeted cancer therapiesPrimary Vaginal Melanoma, A Rare and Aggressive Entity. A Case Report and Review of the Literature.Gefitinib or lapatinib with foretinib synergistically induce a cytotoxic effect in melanoma cell lines.
P2860
Pan-erbB inhibition potentiates BRAF inhibitors for melanoma treatment
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pan-erbB inhibition potentiates BRAF inhibitors for melanoma treatment
@ast
Pan-erbB inhibition potentiates BRAF inhibitors for melanoma treatment
@en
type
label
Pan-erbB inhibition potentiates BRAF inhibitors for melanoma treatment
@ast
Pan-erbB inhibition potentiates BRAF inhibitors for melanoma treatment
@en
prefLabel
Pan-erbB inhibition potentiates BRAF inhibitors for melanoma treatment
@ast
Pan-erbB inhibition potentiates BRAF inhibitors for melanoma treatment
@en
P2093
P2860
P1433
P1476
Pan-erbB inhibition potentiates BRAF inhibitors for melanoma treatment
@en
P2093
Ayesha Khan
Jia-Ying Lee
Jill M Siegfried
John M Kirkwood
Kathryn M Supko
Laura P Stabile
Salina M Torres
Yuen-Keng Ng
P2860
P304
P356
10.1097/CMR.0000000000000060
P407
P577
2014-06-01T00:00:00Z